发布求助
文献互助 智能选刊 最新文献

InFo Hämatologie + Onkologie最新文献

筛选
英文 中文
Adjuvante TKI-Therapie langfristig sicher TKI 辅助治疗长期安全
InFo Hämatologie + Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15004-024-0521-5
Marie-Thérèse Weitzl
{"title":"Adjuvante TKI-Therapie langfristig sicher","authors":"Marie-Thérèse Weitzl","doi":"10.1007/s15004-024-0521-5","DOIUrl":"https://doi.org/10.1007/s15004-024-0521-5","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"478 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140757568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neues Tool, um Nierentoxizität unter Cisplatin abzuschätzen 评估顺铂肾毒性的新工具
InFo Hämatologie + Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15004-024-0525-1
M. Borchers
{"title":"Neues Tool, um Nierentoxizität unter Cisplatin abzuschätzen","authors":"M. Borchers","doi":"10.1007/s15004-024-0525-1","DOIUrl":"https://doi.org/10.1007/s15004-024-0525-1","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"177 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140758246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Innovative Antikörper reduzieren Therapielast 创新抗体减轻治疗负担
InFo Hämatologie + Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15004-024-0556-7
Redaktion Facharztmagazine
{"title":"Innovative Antikörper reduzieren Therapielast","authors":"Redaktion Facharztmagazine","doi":"10.1007/s15004-024-0556-7","DOIUrl":"https://doi.org/10.1007/s15004-024-0556-7","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"137 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140765128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Brustkrebs: Rezidiv- und Krankheitskontrolle 乳腺癌：复发和疾病控制
InFo Hämatologie + Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15004-024-0555-8
Redaktion Facharztmagazine
{"title":"Brustkrebs: Rezidiv- und Krankheitskontrolle","authors":"Redaktion Facharztmagazine","doi":"10.1007/s15004-024-0555-8","DOIUrl":"https://doi.org/10.1007/s15004-024-0555-8","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"425 19","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140780754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pegyliertes liposomales Irinotecan zeigt Wirkung 聚乙二醇脂质体伊立替康显效
InFo Hämatologie + Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15004-024-0549-6
A. Junker
{"title":"Pegyliertes liposomales Irinotecan zeigt Wirkung","authors":"A. Junker","doi":"10.1007/s15004-024-0549-6","DOIUrl":"https://doi.org/10.1007/s15004-024-0549-6","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"1 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140790996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pembrolizumab plus Trastuzumab und Chemotherapie Pembrolizumab 加曲妥珠单抗和化疗
InFo Hämatologie + Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15004-024-0540-2
Fabienne Horr, M. Quante
{"title":"Pembrolizumab plus Trastuzumab und Chemotherapie","authors":"Fabienne Horr, M. Quante","doi":"10.1007/s15004-024-0540-2","DOIUrl":"https://doi.org/10.1007/s15004-024-0540-2","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"190 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140792373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Klinik und Forschung vereinbaren 临床与研究相结合
InFo Hämatologie + Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15004-024-0497-1
Sabrina Sulzer, Tabea Constanze Fröhlich
{"title":"Klinik und Forschung vereinbaren","authors":"Sabrina Sulzer, Tabea Constanze Fröhlich","doi":"10.1007/s15004-024-0497-1","DOIUrl":"https://doi.org/10.1007/s15004-024-0497-1","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"41 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140771699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostik der PNH PNH 的诊断
InFo Hämatologie + Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15004-024-0561-x
B. Höchsmann
{"title":"Diagnostik der PNH","authors":"B. Höchsmann","doi":"10.1007/s15004-024-0561-x","DOIUrl":"https://doi.org/10.1007/s15004-024-0561-x","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"44 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140796338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信